Clinical Trials Logo

CIN clinical trials

View clinical trials related to CIN.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04809727 Completed - Cancer of Cervix Clinical Trials

Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

HSTH
Start date: December 1, 2017
Phase: N/A
Study type: Interventional

Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.

NCT ID: NCT03791606 Completed - CIN Clinical Trials

Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)

PRECISE-ICU
Start date: January 1, 2012
Phase:
Study type: Observational

A retrospective, observational study included all consecutively critically ill patients undergoing percutaneous coronary intervention(PCI) at intensive care unit (ICU) in Fujian Provincial Hospital from January 1st 2012 to December 31st 2018. The aim was to determine the incidence,risk factors,prophylactic strategy and outcomes of CI-AKI in critically ill patients undergoing PCI.

NCT ID: NCT03239223 Completed - Cervical Cancer Clinical Trials

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

Start date: January 1, 2018
Phase: Phase 1
Study type: Interventional

This study evaluates the use of topical ABI-1968 cream, in the treatment of cervical precancerous lesions in adult women.

NCT ID: NCT02363244 Completed - CIN Clinical Trials

Pap and HPVDNA Before and After Acetic Acid

Start date: May 2015
Phase:
Study type: Observational

This is a pilot study to assess the cell adequacy and quality of Pap smears and adequacy of samples for HPV DNA virus test done after application of 5%acetic acid in a VIA test.Normally a Pap test and HPV DNA test is performed before application of acetic acid. It is assumed that application of acetic acid may alter the cell adequacy of Pap test and HPV DNA test, if any of the above tests is done immediately after VIA test.The present study aims to see the effect of 4-5% acetic acid [vinegar] on the cell adequacy and quality of Pap smear and sample adequacy for HPV DNA test.

NCT ID: NCT01766284 Completed - Clinical trials for Cervical Intraepithelial Neoplasia

Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix

PUSHOCTII
Start date: November 2012
Phase: N/A
Study type: Interventional

Optical Coherence Tomography (OCT) is a technology using harmless near infra-red light scatter to produce an image. Prior studies with OCT have demonstrated that OCT of the uterine cervix can differentiate between grades of pre-invasive and invasive cervical disease and cancer. This study will evaluate the ability of the NIRIS 1300e imaging (OCT) system to detect pre-invasive cervical disease and cervical cancer.

NCT ID: NCT00339989 Completed - Cervical Cancer Clinical Trials

Cervical Cancer Early Endpoints and Determinants

Start date: September 12, 2003
Phase:
Study type: Observational

This study, conducted by the National Cancer Institute and the University of Oklahoma, will look for changes in cervix cells and other samples that may be signs of cervical disease. Human papilloma virus, or HPV, is a common infection of the genitalia in women that usually goes away by itself. If HPV infection does not go away, it might turn into cancer of the cervix, although this is rare. This study will examine why many HPV infections go away and why a few persist and lead to cervical cancer. Women 18 years of age and older who are referred for colposcopy (examination of the vagina and cervix using an instrument with a magnifying lens) at the University of Oklahoma following Pap smear diagnosis may be eligible for this study. Women will be in one of the following diagnostic categories: - Cancer: Stage 1-2 only. - Precancer: Cervical intraepithelial neoplasia (CIN3). - HPV-infected: Positive for any of the 13 known cancer-causing HPV types, but not diagnosed with cancer or CIN3. - Normal: Negative for cancer-causing HPV and normal tissue laboratory results. Participants will undergo the following procedures: - Questionnaire: Covers demographic information (such as age, race, ethnicity, marital status, etc.), pregnancy history, menstrual and sexual history, contraceptive history, hormone medication history, medical history, smoking history, physical development, family history, and health care access. - Blood test: 2 tablespoons of blood drawn. - Colposcopy. - Procedure to collect a sample of cervical cells and fluids for HPV testing and research.

NCT ID: NCT00289029 Completed - CIN Clinical Trials

A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography

Start date: July 2005
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue or Visipaque in patients with moderate to severe renal insufficiency undergoing cardiac angiography. Serum creatinine will be measured before and up to 48-72 hours after the administration of the contrast agent to evaluate renal function.